Drug intelligence / Profile preview

Threonine-Aspartic Ester

Development stage: Unknown
Modality: Small Molecules

Overview

Threonine-Aspartic Ester is a chemical compound with the molecular formula C8H16N2O6. It is an ester formed from the amino acids threonine and aspartic acid. While it is listed in databases such as PubChem and DrugBank, and classified under "Pharmaceuticals" in ZINC15, specific information regarding its mechanism of action, therapeutic indications, or development status as a standalone drug is not readily available in the public domain. It may represent a compound of interest for drug discovery or a chemical intermediate.

Other names: (2S,3R)-2-amino-3-((1R,3S)-3-amino-3-carboxy-1-hydroxypropoxy)butanoic acid(2S,3R)-2-amino-3-[(1R,3S)-3-amino-3-carboxy-1-hydroxypropoxy]butanoic acid

Beyond the preview

Go deeper on Threonine-Aspartic Ester.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Threonine-Aspartic Ester.

Explore the full profile